GLYCOVAX.EU
GLYCOVAXGLYCOVAX: A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines.
http://www.glycovax.eu/
GLYCOVAX: A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines.
http://www.glycovax.eu/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.8 seconds
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
15
SITE IP
217.73.229.102
LOAD TIME
0.812 sec
SCORE
6.2
GLYCOVAX | glycovax.eu Reviews
https://glycovax.eu
GLYCOVAX: A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines.
glycovax.eu
GLYCOVAX
http://www.glycovax.eu/impact.html
Glycoconjugate vaccines represent one of the most effective drugs ever discovered. Glycoconjugate vaccines represent one of the most effective drugs ever discovered. Anti-pneumococcal carbohydrate-based vaccines are one of the best seller therapeutics for pharmaceutical companies. After the introduction of this vaccination, in fact, the cases of. Infections dramatically reduced. Glycoscience has seen immense progress over the recent years and new mechanistic insights are emerging in the glycoimmunolo...
GLYCOVAX
http://www.glycovax.eu/background.html
Together with hygiene, vaccines have made possible a great revolution in the 20th century, saving millions of lives. Following the introduction of the anti-pneumococcal represents one of the most important results obtained in the context of glycovaccine field. This project has received funding from the European Union's Horizon 2020. Research and innovation programme under grant agreement No 675671. Follow us on LinkedIn.
GLYCOVAX
http://www.glycovax.eu/index.html
Glycovax Training Event I. GSK Vaccines, Siena - Italy. Glycovax new website online. Last update: October 14, 2016. A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines. Glycoconjugate vaccines represent one of the most effective drugs ever discovered. Read more. The main objective is to train young scientists in rational design of glycoconjugates. Read more. This project has received funding from the European Union's Horizon 2020. Follow us on LinkedIn.
GLYCOVAX
http://www.glycovax.eu/objectives.html
The main objective is to train young scientists in rational design of glycoconjugates. Neonatal infections (Group B streptococci), and nosocomial infections (. Enterococci, Staphylococcus aureus. GLYCOVAX will involve 14 PhD projects well integrated in the four research work packages and interconnected among them. ESRs 4, 6. WP2: Study of carbohydrate-protein interactions. WP2: Study of carbohydrate-protein interactions. ESRs 9, 11, 12. ESRs 8, 9, 10, 11, 12. ESRs 4, 6. WP3: Novel glycoconjugation methods.
GLYCOVAX
http://www.glycovax.eu/fellows.html
Details not yet available. Please come back to visit this page in the next few months. This project has received funding from the European Union's Horizon 2020. Research and innovation programme under grant agreement No 675671. Follow us on LinkedIn.
TOTAL PAGES IN THIS WEBSITE
9
ALTA
http://www.altaweb.it/mission.html
Role and main tasks of ALTA. Why fund raising is necessary? 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy. Tel 39 0577 50518 fax 39 0577 593815. Capitale sociale € 10.845,00. CF 12364330154 P.IVA 01033520527.
ALTA
http://www.altaweb.it/people.html
Maria Grazia De Leon. Communication and Events Manager. 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy. Tel 39 0577 50518 fax 39 0577 593815. Capitale sociale € 10.845,00. CF 12364330154 P.IVA 01033520527.
ALTA
http://www.altaweb.it/news_archive.html
PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020. Health, demographic change and wellbeing:. Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of comorbidities. PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020. Innovative Training Networks (ITN) European Training Networks (ETN):. A training network for the rational design of the next generation of well-defined glycoconjugate vaccines. Probing safety of nano-objects by defining immune responses of environmental organisms. The First ...
ALTA
http://www.altaweb.it/projects.html
Founded in 1998, ALTA is now managing several international projects. In particular, ALTA is involved in research projects of the European Commission in the field of biomedicine and biotechnology. Framework Program, ALTA is directly involved in EU-funded projects as participant for management activities. 18 research projects awarded. Project value € 118.185.078. 17 PEOPLE projects awarded. Project value 19.161.055. 9 research projects awarded. Project value 70.034.208. 7 research projects awarded.
ALTA
http://www.altaweb.it/index.html
Is a service-provider company specialized in developing and managing scientific research projects. The mission of ALTA is to support research activities from the idea to the realization of project. ALTA assists in finding the proper strategy, building European Consortia and putting science in the most appropriate administrative and management framework. PROJECTS APPROVED IN THE 2016-2017 CALL - HORIZON 2020. Climate action, environment, resource efficiency and raw materials. And impact of comorbidities.
ALTA
http://www.altaweb.it/pictures.html
ALTA staff and offices. Princess Anne at the exhibition Hands for Life, Hands for Hope. 25 september 2008 - St. George's - University of London. Complesso Museale S. Maria della Scala - Siena. Mostra fotografica (5 novembre - 13 gennaio 2010). EIMID Meeting - Arc et Senans, France - (October 2008). ALTA celebrates 10 years of activity. 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy. Tel 39 0577 50518 fax 39 0577 593815. Capitale sociale € 10.845,00. CF 12364330154 P.IVA 01033520527.
ALTA
http://www.altaweb.it/old_projects.html
Fungi in the setting of inflammation, allergy and autoimmune diseases: Translating basic science into clinical practices. European Institute of Microbiology and Infectious Diseases. Set up and comparison of multiple stem cell approaches for kidney repair. Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response. European Vaccines and Microbicides Enterprise. New preventative and therapeutic Hepatitis C vaccines: from pre-clinical to phase 1. New carbohydr...
ALTA
http://www.altaweb.eu/news_archive.html
PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020. Health, demographic change and wellbeing:. Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of comorbidities. PROJECTS APPROVED IN THE 2015 CALL - HORIZON 2020. Innovative Training Networks (ITN) European Training Networks (ETN):. A training network for the rational design of the next generation of well-defined glycoconjugate vaccines. Probing safety of nano-objects by defining immune responses of environmental organisms. The First ...
ALTA
http://www.altaweb.eu/mission.html
Role and main tasks of ALTA. Why fund raising is necessary? 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy. Tel 39 0577 50518 fax 39 0577 593815. Capitale sociale € 10.845,00. CF 12364330154 P.IVA 01033520527.
TOTAL LINKS TO THIS WEBSITE
15
glycotrainer.com
Welcome to: glycotrainer.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Let's turn it into a website! Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.
GlycoTrainer | Development Site for GlycoTrainer.com
Development Site for GlycoTrainer.com. We have LIVE CHAT! November 14, 2011. We have made it even easier for you to communicate with us! We have added live chat capabilities to the site. Now, if one of our experts is connected, you can simply click the “Start Chat” link and order products, ask questions, or give your feedback. We expect this will help us communicate better with everyone interested in learning more about glyconutrients. And what we do as social entrepreneurs. Posted in GlycoTrainer.com.
www.glycotreasure.com
This Web page parked FREE courtesy of Domains Priced Right. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $4.99/mo. Call us any time day or night (480) 624-2500.
Automating Carbohydrate Synthesis GlycoUniverse
Of Carbohydrates on Solid Supports. Raquo; Read more. Of glycans and monosaccharide building blocks. Raquo; Read more. To fit all of your needs! First Glyconeer installed in China! Jiangnan University’s MOE Key Laboratory of Carbohydrate Chemistry and Biotechnology at Wuxi is the first research institution in China to have installed a Glyconeer oligosaccharide synthesizer. We welcome Professor Jian Yin and his team as new. Knowledge Base and Forum.
GLYCOVAX
Glycovax Training Event I. GSK Vaccines, Siena - Italy. Glycovax new website online. Last update: October 14, 2016. A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines. Glycoconjugate vaccines represent one of the most effective drugs ever discovered. Read more. The main objective is to train young scientists in rational design of glycoconjugates. Read more. This project has received funding from the European Union's Horizon 2020. Follow us on LinkedIn.
GlycoVaxyn
GlycoVaxyn is a clinical stage biopharmaceutical company focused on the development and manufacture of. Next-generation bioconjugate vaccines utilizing its proprietary recombinant DNA technology. GlycoVaxyn AG sells its shares to GSK. Zurich/Schlieren February 11, 2015. GlycoVaxyn’s innovative biological conjugation platform originates from ETH Zurich and enables the development of a new generation of conjugate vaccines against major bacterial infections. GlycoVaxyn’s proprietary technology makes it ...
GlycoVaxyn
GlycoVaxyn AG sells its shares to GSK. GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological conjugation platform which may help it to develop a new generation of prophylactic vaccines against bacterial infections. GSK has today paid $190 million to purchase the remaining stake in the company, which is valued at $212 million in total. Zurich/Schlieren February 11, 2015. GlycoVaxyn’s innovative biological conjugation platform originates from ETH Zurich and enab...
Glycover
Scroll down to content. May 22, 2017. May 25, 2017. Proudly powered by WordPress.
Glycoviewer - A Glycan visualisation tool
Glycoviewer - A Glycan Visualisation tool. This tool is a visualisation designed to present a set of glycan structures in a concise form, without presenting an overwhelming amount of information. The tool takes advantage of the nature of the biosynthetic pathways used to synthesise the structures, and focuses on presenting information where there are unique features in the structure. By de-emphasising a lot of the conserved structural features, it becomes easier to see the features that are unique. For p...
.
Final TestFrom the Halls of the posters. Four score and seven years ago our forefathers brought forth on this continent a new nation conceived in liberty and dedicated to the proposition that all men are created equal. Now is the time for all good men to come to the aid of their respective companies. Final TestFrom the Halls of the posters.
